New ultrasound device could replace costly MRI for liver disease detection
NCT ID NCT04682600
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study tests a new ultrasound-based device called the Liver Incytes System to see if it can measure liver stiffness and fat as accurately as MRI and FibroScan. The device uses sound waves to create images of the liver, similar to a traditional ultrasound. Researchers are enrolling both healthy volunteers and people with non-alcoholic fatty liver disease (NAFLD) to compare the results from the different methods. If the new device proves reliable, it could offer a simpler and less expensive way to diagnose and monitor liver disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Liver Incytes System (a non-invasive ultrasound-based device that measures liver stiffness and fat using shear wave elastography)
- What this could lead to
- If successful, this could provide a faster, cheaper, and more accessible way to diagnose and monitor liver fibrosis and steatosis without the need for MRI or biopsy.
- What could go wrong
- This is a device comparison study, not a treatment trial. The new device may not prove as accurate as MRI or FibroScan, and results may not change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER FIBROSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Centre
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a promising NAFLD drug safely mix with other medicines? a trial seeks answers
- Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
- Bee product could tame fatty liver and blood fats
- Diabetes drugs may reverse fatty liver damage in new trial
- Can Omega-3 and diet advice tame fatty liver disease?
- Liver damage study in head and neck cancer abandoned after just 2 patients